InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-20.5%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by KLEMP WALTER V, Chairman & CEO. Officer active across 2 companies, notably Moleculin Biotech, Inc.. Cumulatively, 27 disclosures have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €278k. History available since 16 December 2021. The latest transaction was disclosed on 26 December 2023 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations27 total
150 sharesCommon StockSEC:0001437749-26-021611:0
37 sharesCommon StockSEC:0001437749-26-021611:1
360 sharesCommon StockSEC:0001437749-26-021611:2
88 sharesCommon StockSEC:0001437749-26-021611:3
982 sharesCommon StockSEC:0001437749-24-022252:0
8,990 sharesCommon StockSEC:0001437749-24-021197:0
3,750 sharesCommon StockSEC:0001437749-24-020995:0
1,667 sharesCommon StockSEC:0001437749-24-020663:0
188,404 shares@ US$0.6942.4% of flowCommon StockSEC:0001437749-23-035340:0
Ideal exit: 21 Sept 2024 (T+270)
13,204 sharesCommon StockSEC:0001437749-23-019907:0
14,717 sharesCommon StockSEC:0001437749-23-019412:0
56,250 sharesCommon StockSEC:0001437749-23-018140:0
25,000 sharesCommon StockSEC:0001437749-23-017884:0
45,000 shares@ US$1.280719.9% of flowCommon StockSEC:0001437749-22-028116:0
Ideal exit: 22 Aug 2023 (T+270)
22,500 shares@ US$1.14969.0% of flowCommon StockSEC:0001437749-22-027949:0
Ideal exit: 18 Aug 2023 (T+270)
85,213 shares@ US$0.969528.7% of flowCommon StockSEC:0001437749-22-027792:0
Ideal exit: 13 Aug 2023 (T+270)
14,717 sharesCommon StockSEC:0001437749-22-017220:0
13,204 sharesCommon StockSEC:0001437749-22-017219:0
13,204 sharesCommon StockSEC:0001437749-22-017075:0
14,717 sharesCommon StockSEC:0001437749-22-016754:0
25,000 sharesCommon StockSEC:0001437749-22-015536:0
425,000 shares@ US$22.6050.0% of flowCommon StockSEC:0001548187-21-000079
425,000 shares@ US$22.6050.0% of flowCommon StockSEC:0001548187-21-000079:0
13,205 sharesCommon StockSEC:0001437749-21-016790
13,205 sharesCommon StockSEC:0001437749-21-016790:0
25 of 27 declarations
About KLEMP WALTER V
KLEMP WALTER V serves as CEO and President at Moleculin Biotech, Inc. and Soliton, Inc. He is responsible for the strategic and operational direction of both companies. Walter plays a key role in business development and technological innovation, contributing to the growth of Moleculin Biotech and Soliton. His expertise in the biopharmaceutical sector is essential for navigating a competitive environment.
